Aytu Biopharma Inc (NASDAQ:AYTU)
| 1.60 Delayed Data As of Jun 09 |  +0.03 / +1.91%Today’s Change | 1.40 Today|||52-Week Range 16.19 | -57.67% Year-to-Date |
Latest AYTU News | Press Releases
No recent news for Aytu Biopharma Inc.
Today’s Trading
| Previous close | 1.57 |
| Today’s open | 1.55 |
| Day’s range | 1.53 - 1.65 |
| Volume | 21,638 |
| Average volume (3 months) | 75,403 |
| Market cap | $6.9M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -7.67% |
| Earnings growth (this year) | +91.69% |
| Earnings growth (next 5 years) | +69.30% |
| Revenue growth (last year) | +47.29% |
| P/E ratio | NM |
| Price/Sales | 0.21 |
| Price/Book | 0.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NBSENeuBase Therapeutics... | -0.00 | -0.86% |
| KTRAKintara Therapeutics... | 0.00 | 0.00% |
| ADMPAdamis Pharmaceutica... | -0.02 | -0.98% |
| ---- |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | September 27, 2023 |
| EPS forecast (this quarter) | -$1.54 |
| Annual revenue (last year) | $96.7M |
| Annual profit (last year) | -$110.2M |
| Net profit margin | -113.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Englewood, Colorado |
Forecasts
